People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Pharma, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cognito Therapeutics Group, Inc. | — | Pharma | Series D+ | $196.3M | $1.7B | 2025 |
| Cognito Therapeutics Ltd. | — | Pharma | Series D+ | $119.0M | $111.6M | 2022 |
| Markable, Inc. | — | Other Technology | Series A | $8.7M | $40.2M | 2024 |
| FS2 Business, Inc. | — | Other Technology | Seed | $2.6M | $10.3M | 2025 |
Helen Liang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Helen Liang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gerald Chan | 2 | 13 |
| Stephen Bruso | 2 | 9 |
| Richard Kuntz | 2 | 4 |
| Laura Brege | 2 | 3 |
| Jarod Rutledge | 1 | 2 |
| Sheng Fu | 1 | 2 |
| Brent Vaughan | 1 | 1 |
| Jeffrey Halis | 1 | 1 |
| Stephen Ghiglieri | 1 | 1 |
| Zach Malchano | 1 | 1 |
| JULIUS CHIN | 1 | 1 |
| Fiona Wang | 1 | 1 |
| Joy Tang | 1 | 1 |
| Christian Howell | 1 | 1 |
| Jeehwan Kim | 1 | 1 |
| Sanghoon Bae | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.